Genetic risk factors of amyloidogenesis in familial Mediterranean fever

被引:25
作者
Delibas, A
Öner, A
Balci, B
Demircin, G
Bülbül, M
Bek, K
Erdogan, Ö
Baysun, S
Yilmaz, E
机构
[1] Mersin Univ, Fac Med, Dept Pediat Nephrol, Mersin, Turkey
[2] Dr Sami Ulus Childrens Hosp, Dept Pediat Nephrol, Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey
[4] Ondokuz Mayis Univ, Fac Med, Dept Pediat Nephrol, Samsun, Turkey
关键词
familial Mediterranean fever; amyloidosis; familial Mediterranean fever gene; serum amyloid A1 gene; childhood;
D O I
10.1159/000087824
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/ Aims: Evaluation of the risk factors, and phenotype- genotype correlation of familial Mediterranean fever ( FMF) gene ( MEFV) and serum amyloid A1 ( SAA1) gene polymorphisms in renal amyloidosis. Methods: We investigated MEFV and SAA1 genotypes (alpha,beta, and gamma isoforms) in 50 FMF patients and 50 healthy children. Tel- Hashomer criteria were used for the diagnosis and severity scoring of FMF. Results: The most common MEFV mutation and SAA1 genotype were M694V/ M694V ( n = 26/ 50) and SAA1 alpha / alpha ( n = 26/ 50), respectively. Positive family history for amyloidosis was significantly higher ( p < 0.001) with more severe clinical course ( p = 0.006) in the amyloidosis group than the non- amyloid group. In M694V/ M694V mutation, erysipelas-like skin erythema ( p = 0.029), arthritis ( p = 0.004), arthralgia ( p < 0.001) were significantly more frequent with higher severity scores ( p = 0.008) than the patients with other mutations. Comparison of the SAA1 alpha / alpha genotype with other genotypes revealed more frequent arthritis ( p = 0.003) in the SAA1 alpha / alpha genotype. In amyloidosis group patients having both M694V/ M694V and SAA1 alpha/alpha genotypes were the largest subgroup ( n = 14, p < 0.001). Logistic regression analysis for amyloidosis corrected risk revealed a 1.2 times increase in M694V/ M694V, a 2.4 times increase in SAA1 alpha / alpha genotypes and a 2.5 times increase when both are together. Conclusion: Positive family history for amyloidosis and presence of SAA1 alpha / alpha genotype in M694V/ M694V mutation may predispose to amyloidosis by increasing the clinical severity. Therefore, in such children early colchicine treatment might be recommended even if they are asymptomatic. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 40 条
[31]   Infevers: An evolving mutation database for auto-inflammatory syndromes [J].
Touitou, I ;
Lesage, S ;
McDermott, M ;
Cuisset, L ;
Hoffman, H ;
Dode, C ;
Shoham, N ;
Aganna, E ;
Hugot, JP ;
Wise, C ;
Waterham, H ;
Pugnere, D ;
Demaille, J ;
de Menthiere, CS .
HUMAN MUTATION, 2004, 24 (03) :194-198
[32]  
Touitou I, 2001, ARTHRITIS RHEUM-US, V44, P163, DOI 10.1002/1529-0131(200101)44:1<163::AID-ANR20>3.0.CO
[33]  
2-Z
[34]   The spectrum of Familial Mediterranean Fever (FMF) mutations [J].
Touitou, I .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (07) :473-483
[35]   A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey [J].
Tuglular, S ;
Yalcinkaya, F ;
Paydas, S ;
Oner, A ;
Utas, C ;
Bozfakioglu, S ;
Ataman, R ;
Akpolat, T ;
Ok, E ;
Sen, S ;
Düsünsel, R ;
Evrenkaya, R ;
Akoglu, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (11) :2003-2005
[36]   Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever:: evidence for mutation-independent amyloidosis [J].
Yalçinkaya, F ;
Çakar, N ;
Misirlioglu, M ;
Tümer, N ;
Akar, N ;
Tekin, M ;
Tastan, H ;
Koçak, H ;
Özkaya, N ;
Elhan, AH .
RHEUMATOLOGY, 2000, 39 (01) :67-72
[37]   Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients [J].
Yalçinkaya, F ;
Tekin, M ;
Çakar, N ;
Akar, E ;
Akar, N ;
Tümer, N .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (10) :681-684
[38]  
YALCINKAYA F, 2002, CLIN EXP RHEUM S26, V20, pS22
[39]  
Yilmaz E, 2003, TURKISH J PEDIATR, V45, P198
[40]   What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes [J].
Zhang, J ;
Yu, KF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (19) :1690-1691